James P. Maloney - 13 Mar 2025 Form 4 Insider Report for MEDIFAST INC (MED)

Role: Chief Financial Officer
Signature: /s/ Jason L. Groves, attorney-in-fact
Issuer symbol: MED
Transactions as of: 13 Mar 2025
Net transactions value: -$19,581
Form type: 4
Filing time: 18 Mar 2025, 21:27:39 UTC
Previous filing: 19 Mar 2024
Next filing: 27 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MED	Common Stock	Tax liability	$11,581	-835	-4.3%	$13.87	18,699	13 Mar 2025	Direct	F1
transaction	MED	Common Stock	Tax liability	$1,715	-123	-0.66%	$13.94	18,576	16 Mar 2025	Direct	F1
transaction	MED	Common Stock	Tax liability	$6,285	-438	-2.4%	$14.35	18,138	17 Mar 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.

Content

Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.